SearcharxivSearch

arXiv subjects

Martina Amongero

Publications and source records attributed to Martina Amongero.

2 recordsLinked to original sources

Bayesian nonparametric community detection in assortative stochastic block models

Structured data in the form of networks are increasingly common in a number of fields, including the social sciences, biology, physics, computer science, and many others. A key task in network analysis is community detection, which typically consists of dividing the nodes into groups such that nodes within a group are strongly connected, while connections between groups are relatively scarce. A generative model well suited for the formation of such communities is the assortative stochastic block model (SBM), which prescribes a higher probability of a connection between nodes belonging to the same block rather than to different blocks. A recent line of work has utilized Bayesian nonparametric methods to recover communities in the SBM by placing a prior distribution on the number of blocks and estimating block assignments via collapsed Gibbs samplers. However, efficiently incorporating the assortativity constraint through the prior remains an open problem. In this work, we address this gap by studying the effect of enforcing assortativity on Bayesian community detection and identifying the scenarios in which it pays dividends in comparison with standard SBM. We illustrate our findings through an extensive simulation study.

stat.ME

Estimating the optimal time to perform a PET-PSMA exam in prostatectomized patients based on data from clinical practice

Prostatectomized patients are at risk of resurgence, and for this reason, during a follow-up period, they are monitored for Prostate Specific Antigen (PSA) growth, an indicator of tumor progression. The presence of tumors can be evaluated with an expensive exam, called Positron Emission Tomography with Prostate-Specific Membrane Antigen (PET-PSMA). To justify the high cost of the PET-PSMA and, at the same time, to contain the risk for the patient, this exam should be recommended only when the evidence of tumor progression is strong. With the aim of estimating the optimal time to recommend the exam based on the patient's history and collected data, we build a hierarchical Bayesian model that describes, jointly, the PSA growth curve and the probability of a positive PET-PSMA. With our proposal we process all past and present information about the patients PSA measurement and PET-PSMA results, in order to give an informed estimate of the optimal time, improving current practice.

stat.ME